Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2017. Start Trial.
Date Value
November 05, 2026 0.9412
November 04, 2026 0.9879
November 03, 2026 0.9661
November 02, 2026 0.9724
October 30, 2026 1.010
October 29, 2026 1.028
October 28, 2026 1.078
October 27, 2026 1.038
October 26, 2026 0.9786
October 23, 2026 1.000
October 22, 2026 1.013
October 21, 2026 1.024
October 20, 2026 0.9942
October 19, 2026 0.9381
October 16, 2026 0.9007
October 15, 2026 0.9474
October 14, 2026 0.9256
October 13, 2026 0.9412
October 12, 2026 1.053
October 09, 2026 1.097
October 08, 2026 1.081
October 07, 2026 1.063
October 06, 2026 1.125
October 05, 2026 1.153
October 02, 2026 1.153
Date Value
October 01, 2026 1.172
September 30, 2026 1.172
September 29, 2026 1.162
September 28, 2026 1.172
September 25, 2026 1.166
September 24, 2026 1.203
September 23, 2026 1.190
September 22, 2026 1.259
September 21, 2026 1.259
September 18, 2026 1.309
September 17, 2026 1.272
September 16, 2026 1.259
September 15, 2026 1.275
September 14, 2026 1.268
September 11, 2026 1.281
September 10, 2026 1.268
September 09, 2026 1.306
September 08, 2026 1.368
September 04, 2026 1.434
September 03, 2026 1.443
September 02, 2026 1.468
September 01, 2026 1.443
August 31, 2026 1.415
August 28, 2026 1.440
August 27, 2026 1.518

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 17.28
Anika Therapeutics, Inc. 1.638
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 0.9579

Price to Book Value Related Metrics

PEG Ratio -0.0019
Price 3.07
Earnings Yield -36.28%
Market Cap 175.02M
PEGY Ratio -0.0019